« back to GLOBAL TRANSPARENCY PAGE

Massachusetts
overview transparency obligations

Latest update: 14 September 2018 | Important Notes

Report Due Date

July 1 ($2,000 annual fee)

Authority

Massachusetts Pharmaceutical Code of Conduct for Manufacturers

Who Must Report

Pharmaceutical and medical device manufacturers

Covered Recipients

A covered recipient is anyone or any organization that is in a position to decide on prescription drugs and medical devices, see details in text

Pharmaceutical Companies and Medical Device Companies

What is reported:

  • Product education and training
  • Modest meals in conjunction with product education and training
  • Honoraria, consultant, speaker fees and related out-of-pocket expenses
  • Reasonable travel and lodging necessary for training
  • Demonstration or evaluation units
  • Educational gifts (journal articles, anatomical models, textbooks)
  • Charitable donations
Data points to be disclosed:

  • Company ID
  • Covered recipient ID
  • Covered recipient full name
  • Category payment ID
  • Amount of payment
  • Number of events reflected
  • Disclosure report period
  • License type
  • License number

Covered Recipients

A covered recipient is anyone or any organization that is in a position to decide which prescription drugs and medical devices are:

  • Prescribed and dispensed to patients
  • Purchased for patients, e.g., in a hospital or nursing home
  • Recommended for use by a patient as part of a course of treatment or treatment plan
  • Purchased as a diagnostic tool or therapeutic equipment
  • Covered by an insurance provider for subscribers to or participants in a health plan

A covered recipient could be an individual, such as a:

  • Doctor
  • Dentist
  • Pharmacist
  • Nurse practitioner
  • Audiologist
  • Podiatrist
  • Physical therapist

A covered recipient is also the person or persons who decide what prescription drugs or medical devices an employer will allow as part of that company’s employee health benefit plan. Massachusetts-licensed practitioners are covered recipients, regardless of whether they are actively practicing or where they practice.

A covered recipient could be a facility or program, such as a hospital, nursing home, clinic, hospice program, clinical laboratory, home health agency or pharmacy.

How to Report

  • Submit the files as an attachment via email to: Pharmameddata@massmail.state.ma.us
  • All emails containing disclosure report submissions must contain the following information in the subject line of the email:
    • Company name
    • Company MA ID
    • Disclosure year
  • If there are no disclosures to report, Send an email to Pharmameddata@massmail.state.ma.us. In the subject line of the email, include the following:
    • Manufacturer name
    • Manufacturer unique ID
    • “Disclosure report [CALENDAR YEAR]”
    • .

    In the body of the email, simply state “Company A has no reportable spend transactions to report for the 20XX calendar year.”

Note

  • Entertainment/gifts are prohibited
  • All meals must be modest and educational in nature
Important notes:
  • This information is provided for your convenience and should not be construed as legal advice. The applicability of these requirements to your organization depends on individual circumstances. The information is not exhaustive.
  • Kindly check with your legal department and do not depend solely on the information provided here. Moreover, the rules mentioned could be subject to interpretation of local authorities/courts in the applicable jurisdiction. Lastly, be mindful of the latest update mentioned above. These rules and regulations change frequently, so it is important to determine whether the information reflects that most recent changes and is still applicable.
  • Reporting dates are related to the transparency obligation regarding transfers of value by pharmaceutical companies and/or medical device companies (excluding suppliers of in vitro diagnostics) to HCPs and HCOs. These often are based on laws or rules in codes of conduct of industry associations. (In such cases, your company only needs to disclose the transfers of value on the mentioned due date if your company is a member of that association).
  • “Due date” means the date on which the transfers of value need to be published. For example, the deadline for submitting/sending the complete information to the authority could be before the due date to give HCPs/HCOs the opportunity to check the data that the pharmaceutical companies/medical device companies are going to disclose.
  • The information does not take into consideration:
    • Transparency related to clinical trials (unless it concerns transfers of value as mentioned above)
    • Transparency related to patient organizations (unless the patient organization is considered an HCO)
  • If your company is a member of MedTech/EFPIA (or if the industry association your company belongs to is a member of MedTech/EFPIA), the due dates are as mentioned above for MedTech/EFPIA (end of June), unless a law/regulation specifically states otherwise (e.g., the jurisdiction is suspended/exempted from following MedTech/EFPIA).

Disclaimer:

The information contained in this website is for general information purposes only. The information is provided by MediSpend and, while we endeavor to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is, therefore, strictly at your own risk.

In no event will MediSpend be liable for any loss or damage including, without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.

Through this website you may be able to link to other websites which are not under the control of MediSpend. We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.

Every effort is made to keep the website up and running smoothly. However, MediSpend takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.